Abstract:Background Type 1 diabetes (T1D) is an autoimmune disease resulting from an attack by autoreactive T lymphocytes against pancreatic islet beta- cells. In recent studies, regulatory T cells (Tregs) have been implicated in the process of T1D. Furthermore, cluster of differentiation 39 (CD39), which is involved in the suppression of inflammation, has been shown to be expressed on Tregs. However, the pathological importance of CD39 to the memory Treg population remains unclear. Methods This study investigated Treg subsets, focusing on resting, effector, and memory Tregs, and determined CD39 expression on Tregs. In addition, changes in Treg subsets and Treg-associated cytokine secretion after CD3/CD28 stimulation of peripheral blood mononuclear cells were evaluated in diabetic patients and healthy controls. The suppressive function of Tregs was measured using the mixed lymphocyte reaction (MLR) test. Results There was a higher percentage of memory Tregs in T1D patients than healthy controls. However, Tregs in T1D patients showed impaired suppression, with low forkhead box P3 (Foxp3) expression and low serum interleukin (IL)-10 levels. Furthermore, CD39 expression on Tregs, and on memory Tregs in particular, was lower in T1D patients than healthy controls. After stimulation, the percentage of resting Tregs was decreased and that of effector/memory Tregs was increased in both healthy controls and T1D patients, but CD39 expression on effector/memory Tregs was still lower and there was no increase in IL-10 secretion in T1D patients. Conclusions The defective suppressive function of Tregs in T1D patients is due to lower expression of CD39 on memory Tregs.

Alteration of Regulatory T Cells in Type 1 Diabetes Mellitus: A Comprehensive Review

Regulatory T Cells and Type 1 Diabetes

Regulatory T Cells And Diabetes Mellitus

Regulatory T cell-based therapy in type 1 diabetes: Latest breakthroughs and evidence

Umbilical cord blood and peripheral blood-derived regulatory T cells therapy: Progress in type 1 diabetes

Biological function of type 1 regulatory cells and their role in type 1 diabetes

Changes of regulatory T cells, transforming growth factor-beta and interleukin-10 in patients with type 1 diabetes mellitus: A systematic review and meta-analysis

New Developments in T Cell Immunometabolism and Therapeutic Implications for Type 1 Diabetes

Autoimmune CD8+ T cells in type 1 diabetes: from single-cell RNA sequencing to T-cell receptor redirection

Essential Roles Of Tgf-Beta In Anti-Cd3 Antibody Therapy: Reversal Of Diabetes In Nonobese Diabetic Mice Independent Of Foxp3(+) Cd4(+) Regulatory T Cells

Immune Regulation in T1D and T2D: Prospective Role of Foxp3+ Treg Cells in Disease Pathogenesis and Treatment

Transcriptional Control of Pancreatic Β-Cell Identity and Plasticity During the Pathogenesis of Type 2 Diabetes.

Induced Regulatory T Cells Suppress Tc1 Cells Through TGF-β Signaling to Ameliorate STZ-induced Type 1 Diabetes Mellitus

Mechanisms and therapeutic strategies of immune checkpoint molecules and regulators in type 1 diabetes

miRNA Regulation of T Cells in Islet Autoimmunity and Type 1 Diabetes

Foxp3-expressing CD4+T Cells under the Control of IFN-γ Promoter Prevent Diabetes in NOD Mice

Genetic engineering of regulatory T cells for treatment of autoimmune disorders including type 1 diabetes

Altered expression of CD39 on memory regulatory T cells in type 1 diabetes patients.

The role of islet autoantigen-specific T cells in the onset and treatment of type 1 diabetes mellitus

Type 1 diabetes mellitus and its oral tolerance therapy

Type 1 diabetes: immune pathology and novel therapeutic approaches